serine has been researched along with Basal Ganglia Diseases in 3 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnuma, T | 1 |
| Sakai, Y | 1 |
| Maeshima, H | 1 |
| Higa, M | 1 |
| Hanzawa, R | 1 |
| Kitazawa, M | 1 |
| Hotta, Y | 1 |
| Katsuta, N | 1 |
| Takebayashi, Y | 1 |
| Shibata, N | 1 |
| Arai, H | 1 |
| Guillozet-Bongaarts, AL | 1 |
| Glajch, KE | 1 |
| Libson, EG | 1 |
| Cahill, ME | 1 |
| Bigio, E | 1 |
| Berry, RW | 1 |
| Binder, LI | 1 |
| Usui, S | 1 |
| Komiya, T | 1 |
| Imai, H | 1 |
| Narabayashi, H | 1 |
3 other studies available for serine and Basal Ganglia Diseases
| Article | Year |
|---|---|
No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Alanine; Antipsychotic Agents; Basal Ganglia Diseases; Biomarkers; Brief Ps | 2012 |
Phosphorylation and cleavage of tau in non-AD tauopathies.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Astrocytes; Basal Ganglia Diseases; Female; Humans; Immunohi | 2007 |
[Metrizamide encephalopathy in a child with hydrocephalus--effects of L-threo-DOPS on persistent disturbance of consciousness and L-dopa on extrapyramidal symptoms].
Topics: Basal Ganglia Diseases; Brain; Brain Diseases; Child; Cognition Disorders; Consciousness Disorders; | 1988 |